No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in 1984 in Gurugram, India, Morepen Laboratories Limited is a pharmaceutical company involved in the development, production, distribution, and marketing of active pharmaceutical ingredients (APIs), a wide array of formulations, and various home healthcare solutions. Its operations extend across India, the United States, and other international markets. The company's API portfolio encompasses compounds utilized in medications targeting diverse conditions such as allergies, asthma, high cholesterol, hypertension, diabetes, blood coagulation issues, gout, depression, and malaria. Its range of home health and diagnostic products features items like air purifiers, blood pressure and glucose monitoring devices (including strips), sphygmomanometers, stethoscopes, digital thermometers, nebulizers, vaporizers, heat belts, and pulse oximeters. Additionally, Morepen provides a selection of over-the-counter (OTC) remedies under specific brand names: Fever X for fever relief, Pain X for pain management, Fiber-X as a sat isabgol supplement, Acidity X for digestive relief, and Burnol for the treatment of minor burns. Beyond these, its formulated pharmaceutical products address numerous therapeutic areas, including nutrition, probiotics, gastroenterology, antibiotics, gynecology, anti-allergies, central nervous system disorders, cardiology, diabetology, and nutraceuticals. Many of its consumer-facing offerings, particularly OTC products, are marketed under the prominent Dr. Morepen brand.
www.morepen.comNo one on the platform currently holds MOREPENLAB.BO.
No tracked institution reports a position in MOREPENLAB.BO as of their last filing.
No one on the platform has traded MOREPENLAB.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MOREPENLAB.BOMorepen Laboratories Limited | $106.25 | -8.37% | $58.3B | — |
| ALEMBICLTD.NSAlembic Limited | $100.51 | -3.66% | $25.8B | — |
| HIKAL.BOHikal Limited | $212.35 | -6.47% | $26.1B | — |
| INDOCO.BOIndoco Remedies Limited | $242.05 | -7.91% | $22.2B | — |
| INDOCO.NSIndoco Remedies Limited | $241.39 | -8.22% | $22.2B | — |
| IOLCP.BOIOL Chemicals and Pharmaceuticals Limited | $179.45 | -7.26% | $52.7B | — |
| IOLCP.NSIOL Chemicals and Pharmaceuticals Limited | $179.52 | -7.61% | $52.7B | — |
Source: Financial Modeling Prep · peers by sector/industry